[1] Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons

[2] Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

[3] Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis